vimarsana.com

Page 5 - பல்கலைக்கழகம் ஆஃப் கொலராடோ புற்றுநோய் மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BioSpace Movers & Shakers, May 21

Published: May 21, 2021 By Alex Keown Biopharma and life sciences companies strengthen their leadership teams and board with these Movers & Shakers.  AavantiBio – Jessie Hanrahan was named chief regulatory officer of AavantiBio. Hanrahan will oversee global regulatory affairs for AavantiBio’s diversified pipeline of gene therapy programs targeting rare diseases with significant unmet medical needs. Most recently, she was Vice President of Regulatory Science at bluebird bio, Inc. Prior to bluebird bio, Hanrahan held positions of increasing responsibility at Genzyme Corp. where she worked across the oncology, multiple sclerosis and rare disease therapeutic areas. Earlier in her career, Hanrahan worked at Boston Scientific Corporation.

NCI-designated cancer centers call for action to get HPV vaccination back on track

 E-Mail IMAGE: HPV infection causes cells to undergo changes. If not treated these cells can, over time, become cancer cells. view more  Credit: National Cancer Institute Today, doctors and scientists across America at National Cancer Institute (NCI)-designated cancer centers and other organizations issued a joint statement urging the nation s health care systems, physicians, parents and children, and young adults to get the human papillomavirus (HPV) vaccination back on track. Dramatic drops in annual well visits and immunizations during the COVID-19 pandemic have caused a significant vaccination gap and lag in vital preventive services among U.S. children and adolescents especially for the HPV vaccine. The pandemic also has exacerbated health disparities, leaving Black, Indigenous and other people of color; rural; and sexual minority adolescents at even greater risk for missed doses of this cancer prevention vaccine.

Obituary: Peter B Lyons Feb 23, 1943 – April 29, 2021

Obituary: Peter B. Lyons Feb. 23, 1943 – April 29, 2021 Feb. 23, 1943 – April 29, 2021 Peter B. Lyons passed away in Golden, Colorado on Friday, April 29, 2021, following a yearlong battle with cancer. Pete’s partner Peggy Lyon-Bull and his sons Daniel, David and Michael were able to join him at his side in his final hours. He leaves behind a legacy of dedication to his family, to the scientific community and to the nation for a life spent in public service. Pete was born to Leland and Rita (nee Horblit) Lyons in Hammond Indiana, in 1943. Although born in the midwest, he spent his childhood in Boulder City, Nevada, just outside of Las Vegas, Nevada. During his time in Nevada, he developed a passion for the geology and topography of the American southwest. He was a standout student at the small high school and also excelled as a tennis player in the then sparsely populated state. He went on to become Nevada state champion in tennis while in high school. He later joked that th

CU Cancer Center researchers receive PRCRP grant to investigate metastasis

CU Cancer Center researchers receive PRCRP grant to investigate metastasis Two members of the University of Colorado Cancer Center have received prestigious Idea Awards from the U.S. Department of Defense s Peer Reviewed Cancer Research Program (PRCRP). Founded in 2009, the PRCRP funds cancer research to support service members, their families, and the American public. Since members of the military are exposed to hazardous environments due to the nature of their service and are at risk for the development of many types of cancers, the PRCRP s mission is to promote high-impact research for cancer prevention, detection, treatment, and survivorship. CU Cancer Center mentored member Masanori Hayashi, MD, a pediatric oncologist at Children s Hospital Colorado, received a PRCRP grant for his investigation into Ewing sarcoma, a cancer that affects children and young adults. Seventy percent of Ewing sarcoma patients respond well to a combination of chemotherapy and surgery, but 30% of pat

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.